Access to vaccine technologies in developing countries: Brazil and India

Vaccine

Volumn 25, Issue 44, 2007, Pages 7610-7619

  Milstien, Julie B ^a   Gaulé, Patrick ^b   Kaddar, Miloud ^c  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b EPFL   (Switzerland)

^c WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

Intellectual property rights; Technology transfer; Vaccine innovation

Indexed keywords

ARTICLE; BRAZIL; DEVELOPING COUNTRY; DRUG INDUSTRY; DRUG MARKETING; DRUG RESEARCH; HEALTH CARE ACCESS; HEALTH CARE ORGANIZATION; HEALTH PROGRAM; INDIA; MANAGEMENT; MARKET; MEDICAL LITERATURE; MEDICAL TECHNOLOGY; PATENT; PRIORITY JOURNAL; PROFESSIONAL COMPETENCE; VACCINE PRODUCTION;

EID: 35148815739     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.09.007     Document Type: Article

References (14)

1. World Health Assembly. Public health, innovation, essential health research and intellectual property rights: towards a global strategy and plan of action. WHA 59.24; 2006.
2. Milstien J., and Kaddar M. Managing the effect of TRIPS on availability of priority vaccines. Bull World Health Organ 84 5 (2006) 360-365
3. Mahoney R., Lee K., and Yun M. Intellectual property, drug regulation, and building product innovation capability in biotechnology: the case of hepatitis B vaccine in Korea. Innovation Strategy Today 1 2 (2005) 33-45
4. Commission on Intellectual Property Rights, Innovation and Public Health. Public health: innovation and intellectual property rights. Geneva: WHO; 2006. Available from http://www.who.int/intellectualproperty/report/en/index.html.
5. World Health Organization. Intellectual property rights and vaccines in developing countries. Meeting Report. Geneva: WHO; 2004. Available from http://www.who.int/intellectualproperty/events/vaccines_meeting/en/index .html [WHO document WHO/IVB/04.21.]
6. IPR commission. Integrating intellectual property rights and development policy. Report of the UK commission on IPR; 2002.
7. Expert Committee on Biological Standardization. Procedure for evaluating the acceptability in principle of vaccines proposed to United Nations agencies for use in immunization programmes. Technical Report Series 760, Annex 1; 1987.
8. World Health Organization. Expanded programme on immunization global advisory group. Wkly Epidemiol Rec 67 3 (1992) 11-16
9. Boston Consulting Group. Global vaccine supply: the changing role of suppliers, a report commissioned for GAVI by WHO and the World Bank; 2005. Available from http://www.gavialliance.org/resources/BCG_24_June.pdf, accessed 19 September 2007.
10. Oliveira M.A., Bermudez J., Chaves G., and Velazquez G. Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?. Bull World Health Organ 82 11 (2004) 815-821
11. Basso M. Intervention of health authorities in patent examination: the Brazilian practice of the prior consent. Int J Intellect Property Manage 1 1-2 (2006) 5-74
12. Basso M. India's tryst with TRIPS: the Patents (Amendment) Act. Indian J Law Technol 1 1 (2005) 15-46
13. Frew S.E., Rezaie R., Sammut S.M., Ray M., Daar A.S., and Singer P.A. India's health biotech sector at a crossroads. Nat Biotechnol 25 4 (2007) 403-417
14. Granstrand O. The economics and management of intellectual property: towards intellectual capitalism (1999), Edward Elgard Publishing Ltd., London